
Opinion|Videos|December 24, 2024
Comparing and Contrasting the Current Armamentarium for Treating Atopic Dermatitis
Author(s)James Song, MD, FAAD
Key Takeaways
A panelist discusses how the current treatment options for atopic dermatitis range from topical corticosteroids and calcineurin inhibitors for mild cases to systemic medications such as dupilumab and Janus kinase inhibitors for moderate-to-severe disease, with selection based on factors such as disease severity, patient age, and safety considerations.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Grants Breakthrough Therapy Designation to Litifilimab for Cutaneous Lupus Erythematosus
2
How Galderma is Modernizing Aesthetic Trends and Patient Outcomes Around the World
3
Del Rosso's What's New in the Medicine Chest 2026: CHE, CSU, and Vitiligo
4
Dermatology Times January 2026 Print Recap
5















